MAY 10, 2019 10:05 AM PDT

Make sure you schedule a morning appointment with your doctor

You may want to reschedule that late afternoon doctor’s appointment. A new study published today in JAMA Network Open suggests that primary care doctors are less likely to order cancer screenings for patients they see later in the day. The information comes from researchers in the Perelman School of Medicine and the Wharton School both of the University of Pennsylvania and speaks toward the heavy loads that are put on medical professionals’ schedules.

"Our findings suggest that future interventions targeting improvements in cancer screening might focus on time of day as an important factor in influencing behaviors," said the study's lead author, Esther Hsiang, a Wharton Business School student and researcher with the Penn Medicine Nudge Unit. "We believe that the downward trend of ordering may be the result of 'decision fatigue,' where people may be less inclined to consider a new decision after they've been making them all day. It may also stem from overloaded clinicians getting behind as the day progresses."

The research team came to this conclusion after analyzing data from general practitioners’ offices in Pennsylvania and New Jersey from 2014-2016. They found that PCPs were more likely to order breast cancer and colon cancer screening tests for patients at 8:00 in the morning than for patients at 5:00 in the afternoon. The differences were significant, with doctors ordering breast cancer screenings 64% versus 48% of the time, and colon cancer screenings 37% versus 23% of the time, respectively.

Scarily enough, these numbers add up and have substantial impacts: morning-appointment patients are way more likely to complete screenings like mammograms and colonoscopies than afternoon-appointment patients. For breast cancer screenings, those patients who completed screenings fell from 33% at 8 AM to 18% at 5 PM; for colorectal cancer screenings, the numbers were 28% versus 18%.

What time of day do you usually see your doctor? Photo: Pixabay

The researchers’ work suggests how technology could compensate for sure shortcomings in the care provided by doctors. "Our new study adds to the growing evidence that time of day and decision fatigue impacts patient care," said Mitesh Patel, MD, MBA, director of the Penn Medicine Nudge Unit and an assistant professor of Medicine. "In past work, we've found that nudges in the electronic health record can be used to address these types of gaps in care, which we suspect will be the case here. Future research could evaluate how nudges may be implemented in order to improve cancer screening." A previous study regarding flu vaccinations used this nudge technology to remind clinicians to ask their patients about flu vaccines and showed success, with a 20% rise in vaccinated patients.

Sources: Medical Xpress, Eureka Alert!

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 01, 2020
Cancer
APR 01, 2020
New immunotherapy for ovarian cancer
Research published recently in the Journal of Experimental Medicine suggests that targeting macrophages in a new kind of ...
APR 14, 2020
Immunology
APR 14, 2020
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
Lung cancer is the leading cause of death in both men and women in the U.S., with smokers bearing an elevated risk of th ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Drug Targets Hard To Treat Uterine Cancer
A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The dru ...
MAY 13, 2020
Cell & Molecular Biology
MAY 13, 2020
Combined with Fasting-Mimicking Diet, Vitamin C May Have Anti-Cancer Effect
People have long been searching for natural ways to treat cancer in an effort to avoid some of the harmful side effects ...
MAY 17, 2020
Cancer
MAY 17, 2020
Text message reminders don't cut it
New research published in the Journal of Clinical Oncology shows that contrary to previous investigations’ results ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
Approved Treatment for RET-mutant Cancers
A drug was recently approved for treating three types of RET-mutant cancers: 1) non-small cell lung cancer (NSCLC) 2) ad ...
Loading Comments...